MiR-181a regulates inflammation responses in monocytes and macrophages - PubMed (original) (raw)

MiR-181a regulates inflammation responses in monocytes and macrophages

Weidong Xie et al. PLoS One. 2013.

Abstract

miR-181a has been presumed to target the 3'-untranslated regions (3'-UTR) of IL1a based on software predictions. miR-181a and IL1a have opposite expression levels in monocytes and macrophages in the inflammatory state. This led us to suspect that mir-181a has an important function in regulating inflammatory response by targeting IL1a. Fluorescence reporter assays showed that miR-181a effectively binds to the 3'-UTR of IL1a. The anti-inflammatory functions of miR-181a were investigated in lipopolysaccharides (LPS)-induced Raw264.7 and phorbol 12-myristate 13-acetate (PMA)/LPS-induced THP-1 cells. We found that miR-181a mimics significantly lowered IL1a expression levels in these cells and, interestingly, miR-181a inhibitors reversed this decrease. In addition, miR-181a mimics significantly inhibited increase in the levels of inflammatory factors (IL1b, IL6, and TNFa) in these cells. Furthermore, miR-181a mimics and inhibitors decreased and increased, respectively, production of reactive oxygen species in PMA/LPS-induced THP-1 cells. These results indicate that miR-181a regulates inflammatory responses by directly targeting the 3'-UTR of IL1a and down-regulating IL1a levels. Interestingly, we found that miR-181a inhibited production of inflammatory factors even in IL1a-induced THP-1 cells, suggesting that the anti-inflammatory effects of miR-181a possibly involves other targets in addition to IL1a. Thus, we provide the first evidence for anti-inflammatory effects of miR-181a mediated at least in part by down-regulating IL1a.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1

Figure 1. Presumed binding sites for miR-181a in the 3′-UTR of mouse and human IL1a.

The binding sites are highly conserved.

Figure 2

Figure 2. (A and B) miR-181a expression in LPS-induced Raw264.7 cells and PMA/LPS-induced THP-1 cells; (C and D) intracellular IL1a levels in LPS-induced Raw264.7 cells and PMA/LPS-induced THP-1 cells; (E) effects of miR-181a mimics on chemiluminescence values in Cos-7 cells (transfected with pRLTK containing L1a-3′-UTR or its mutated variant).

Data are expressed as mean ± SD (n = 3), **P<0.01 vs. values at 0 h (A–D), **P<0.01 vs. negative control (NC, E).

Figure 3

Figure 3. Effects of miR-181a mimics and inhibitors on IL1a and IL1b mRNA levels in LPS-induced Raw264.7 (A) and PMA/LPS-induced THP-1 cells (B); effects of miR-181a mimics and inhibitors on ILa, IL1b, IL6, and TNFa in cell lysates and media of LPS-induced Raw264.7 (C and E) and PMA/LPS-induced THP-1 cells (D and F) assayed by ELISA.

Data are expressed as mean ± SD (n = 3), **P<0.01 vs. negative control (NC), # P<0.05, ## P<0.01 vs. miRNA inhibitor negative control (NC-i). ‘NC-i’ is a single stranded nucleic acid used as negative control for miR-181a inhibitors (181a–i). ‘LPS + or −’, cells were treated with or without LPS in the case of Raw264.7 cells or PMA/LPS in the case of THP-1 cells.

Figure 4

Figure 4. Effects of miR-181a mimics and inhibitors on ILa levels in cell lysis solution of LPS-induced Raw264.7 (A) and PMA/LPS-induced THP-1 cells (B) assayed by Western blot.

Data are expressed as mean ± SD (n = 3–5), **P<0.01 vs. negative control (NC), ## P<0.01 vs miRNA inhibitor negative control (NC-i). ‘NC-i’ is a single-stranded nucleic acid used as negative control for miR-181a inhibitors (181a–i). Effects of miR-181a precursors (pre-miR-181a) and its inhibitors on ILa, IL1b, IL6, and TNFa in cell lysates and culture media of PMA/LPS-induced THP-1 cells (C and D) assayed by ELISA. Data are expressed as mean ± SD (n = 3), *P<0.05, **P<0.01 vs. negative control (pre-NC), # P<0.05 vs. miRNA inhibitor negative control (pre-NC-i). ‘pre-NC-i’ is a single-stranded nucleic acid used as negative control for miR-181a inhibitors (pre-miR-181a–i). ‘LPS + or −’, cells were treated with or without LPS in the case of Raw264.7 cells or PMA/LPS in the case of THP-1 cells.

Figure 5

Figure 5. Effects of stable expression of miR-181a on production of inflammatory factors in LPS-induced Raw264.7 cells.

(A) pCMV recombinant Raw264.7 cells (CMV, negative controls); (B) pCMV-pre-miR-181a recombinant Raw264.7 cells (SC); (C) endogenous miR-181a expression in SC (containing miR-181a expression vector) and CMV (containing negative control vector) cells; (D) Expression of IL1a in pCMV and pCMV-pre-miR-181a recombinant Raw264.7 cells assayed by Western blotting; (E and F) Levels of IL1a, IL1b, IL6, and TNFa in cell lysis solution and culture media of recombinant Raw264.7 cells transfected with pCMV and pCMV-pre-miR-181a. Data are expressed as mean ± SD (n = 3), *P<0.05, **P<0.01 vs. pCMV recombinant controls induced by LPS (CMV LPS+), ## P<0.01 vs. miRNA inhibitor negative control (NC-i). LPS+ and LPS− indicate that cells were treated with and without LPS, respectively.

Figure 6

Figure 6. (A and B) Effects of transient transfection with miR-181a expression vector on the levels of ILa, IL1b, IL6, and TNFa in PMA/LPS-induced THP-1 cell lysis solution and culture media.

Data are expressed as mean ± SD (n = 3), *P<0.05, **P<0.01 vs. CMV controls. ‘SC’, pCMV-pre-miR-181a recombinant THP-1 cells; ‘CMV’, pCMV recombinant THP-1 cells (negative controls). (C and D) Effects of si-IL1a on the mRNA levels of IL1a and IL1b in LPS-induced Raw264.7 and PMA/LPS-induced THP-1 cells. (E and F) Effects of si-IL1a on the levels of IL1a, IL1b, IL6, and TNFa in LPS-induced Raw264.7 and PMA/LPS-induced THP-1 cells. Data are expressed as mean ± SD (n = 3), *P<0.05, **P<0.01 vs. negative control (NC). ‘siNC’ is a single-stranded nucleic acid used as negative control for siIL1a.

Figure 7

Figure 7. Effects of miR-181a mimics and inhibitors on the levels of IL1a, IL1b, IL6, and TNFa in IL1a-induced THP-1 cell lysis solution (A) and culture medium (B).

Data are expressed as mean ± SD (n = 3), *P<0.05, **P<0.01 vs. negative control (NC), # P<0.05 vs. miRNA inhibitor negative control (NC-i). ‘NC-i’ is a single-stranded nucleic acid used as a negative control for miR-181a inhibitors (181a–i). IL1a + and IL1a- indicate that the cells were treated with (at a final concentration of 0.1 ng/ml) and without exogenous IL1a, respectively.

Figure 8

Figure 8. Effects of miR-181a mimics and inhibitors on the productions of reactive oxygen species (ROS) in PMA/LPS-induced TPH-1 cells.

Data are expressed as mean ± SD (n = 3), **P<0.01 vs. negative control (NC), ## P<0.01 vs. miRNA inhibitor negative control (NC-i). ‘NC-i’ is a single-stranded nucleic acid used as negative control for miR-181a inhibitors (181a–i). LPS+ and LPS− indicate cells treated with and without PMA/LPS, respectively.

Figure 9

Figure 9. Potential effects and mechanisms of the regulation of inflammation by miR-181a.

Similar articles

Cited by

References

    1. Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE (2007) Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol 147: 227–235. - PMC - PubMed
    1. Xie W, Du L (2011) Diabetes is an inflammatory disease: evidences from traditional Chinese Medicines. Diabetes Obes Metab 13: 289–301. - PubMed
    1. Johnson AR, Justin Milner J, Makowski L (2012) The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev 249: 218–238. - PMC - PubMed
    1. Taube A, Schlich R, Sell H, Eckardt K, Eckel J (2012) Inflammation and metabolic dysfunction: links to cardiovascular diseases. Am J Physiol Heart Circ Physiol 302: H2148–2165. - PubMed
    1. Vendramini-Costa DB, Carvalho JE (2012) Molecular Link Mechanisms between Inflammation and Cancer. Curr Pharm Des 18: 3831–3852. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

This study was supported by the National Natural Science Foundation of China (81072680), the Guangdong Natural Science Foundation (10151805702000002), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20100002120017), and the Shenzhen Science and Technology R&D Foundation (ZYC201105170341A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

LinkOut - more resources